Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns

The inspection comprised a routine current Good Manufacturing Practices (cGMP) review along with a Pre-Approval Inspection (PAI), the company said in a regulatory filing.

Leave a Reply

Your email address will not be published. Required fields are marked *